These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27188360)

  • 1. [Analysis on antiretroviral therapy efficacy for HIV/AIDS in Zhejiang province, 2009-2014].
    Zheng JL; Xu Y; He L; Jiang J; Zhang JF; Zhang WJ; Ding XB; Yang JZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):673-7. PubMed ID: 27188360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early highly active antiretroviral therapy on viral suppression among newly diagnosed men who have sex with men living with human immunodeficiency virus in Xi'an, China.
    Wei X; Zhang Y; Santella AJ; Wang L; Zhuang G; Li S; Zhang H
    J Med Virol; 2019 Jul; 91(7):1263-1271. PubMed ID: 30840771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A cross-sectional study on HIV/AIDS "90-90-90" treatment target in Shandong province, 2015].
    Zhang N; Huang T; Yang XG; Wang GY; Tao XR; Kang DM; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1367-1371. PubMed ID: 29060981
    [No Abstract]   [Full Text] [Related]  

  • 5. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali.
    Merci NM; Emerence U; Augustin N; Habtu M; Julie I; Angelique T; Jessica B; Cynthia A; Penda AT
    Pan Afr Med J; 2017; 26():14. PubMed ID: 28450993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Body Composition and Other Clinical Factors with Incomplete Immune Response after Highly Active Antiretroviral Therapy.
    Sun PT; Yu W; Li TS; Lin Q; Guo FP; Zhou XH; Du GY; Xu Y; Guan WM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):459-464. PubMed ID: 28877821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival analysis of HIV/AIDS patients with access to highly antiretroviral therapy in Ningbo during 2004-2015].
    Zhang JH; Li HL; Shi HB; Jiang HB; Hong H; Dong HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Sep; 37(9):1262-1267. PubMed ID: 27655575
    [No Abstract]   [Full Text] [Related]  

  • 8. Associated factors for progression to AIDS among HIV-infected people who use drugs: a retrospective cohort study in Dongguan, China.
    Luo H; Sun M; Du J
    BMJ Open; 2019 Jul; 9(7):e023841. PubMed ID: 31272970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival status and influencing factors of HIV/AIDS on highly active anti-retrovial therapy in Shandong province].
    Zhang N; Zhu XY; Wang GY; Tao XR; Wang N; Kang DM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jan; 40(1):74-78. PubMed ID: 30669735
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A retrospective cohort study on survival status of AIDS patients among 15 or above-year-olds in Henan province, from 2008 to 2015].
    Yang WJ; Li N; Liang Y; Li J; Fan PY; Sun DY; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):173-178. PubMed ID: 28231661
    [No Abstract]   [Full Text] [Related]  

  • 13. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
    Seyoum A; Ndlovu P; Temesgen Z
    AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunologic outcomes of HAART-treated HIV-infected women in resource constrain settings: the Belgrade Study.
    Dragović G; Salemović D; Ranin J; Nikolić J; Kušić J; Jevtović D
    Women Health; 2014; 54(1):35-47. PubMed ID: 24555810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with 10 years of continuous viral load suppression on HAART.
    Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
    BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival time of HIV/AIDS cases and influencing factors in Gansu province, 1997-2018].
    Li J; Li H; Yu AL; Wang B; Wang XR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1398-1402. PubMed ID: 31838811
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
    Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
    PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CD(4+) T lymphocyte responses to anti-retroviral therapy, among HIV/AIDS patients aged 18 and over].
    Guo XX; Ma Y; Dou ZH; Wu YS; Zhao DC; Cai WP; Li Y; Dong XX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jun; 38(6):740-745. PubMed ID: 28647974
    [No Abstract]   [Full Text] [Related]  

  • 20. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.